H.C. Wainwright analyst Ed Arce maintained a Hold rating on Iterum Therapeutics (ITRM – Research Report) today. The company’s shares
Tag: NASDAQ:ITRM
Iterum Therapeutics (ITRM) Receives a Hold from H.C. Wainwright
In a report released today, Ed Arce from H.C. Wainwright maintained a Hold rating on Iterum Therapeutics (ITRM – Research
Iterum Therapeutics (ITRM) Receives a Hold from H.C. Wainwright
H.C. Wainwright analyst Ed Arce maintained a Hold rating on Iterum Therapeutics (ITRM – Research Report) today. The company’s shares
RBC Capital Remains a Hold on Iterum Therapeutics (ITRM)
RBC Capital analyst Gregory Renza maintained a Hold rating on Iterum Therapeutics (ITRM – Research Report) yesterday and set a
Needham Keeps a Buy Rating on Iterum Therapeutics (ITRM)
Needham analyst Alan Carr maintained a Buy rating on Iterum Therapeutics (ITRM – Research Report) today and set a price
H.C. Wainwright Keeps Their Buy Rating on Iterum Therapeutics (ITRM)
In a report released yesterday, Ed Arce from H.C. Wainwright maintained a Buy rating on Iterum Therapeutics (ITRM – Research
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Iterum Therapeutics